The oil-red-O staining showed that the lipid accumulation in sucralose-consuming mice was greatly reduced by supplementation with metformin or FOS (Fig. 6L), indicating that NAFLD induced by sucralose consumption was highly improved. Here, FOS is linked to metabolic dysfunction-associated steatotic liver disease.